SARS-CoV-2 Antiviral Immunofluorescence staining Protocol v1
DOI:
10.17504/protocols.io.261ge5jnog47/v1
Publication Date:
2025-03-18T21:51:13Z
AUTHORS (1)
ABSTRACT
This protocol describes immunofluorescence staining of fixed SARS-CoV-2 infected cells using IC7C7 primary antibody (produced in house against SARS-CoV-2 NP) and Alexa Fluor 488-conjugated secondary antibody. The procedure results in fluorescently labeled infected cells for quantification of viral infection.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....